Free Trial
NASDAQ:GNCA

Genocea Biosciences (GNCA) Stock Price, News & Analysis

Genocea Biosciences logo

About Genocea Biosciences Stock (NASDAQ:GNCA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
83,499 shs
Market Capitalization
$6 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genocea Biosciences and its competitors with MarketBeat's FREE daily newsletter.

GNCA Stock News Headlines

Genocea Biosciences Inc GNCAQ
GNCAQ Genocea Biosciences, Inc.
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Genocea Biosciences, Inc. (GNCA)
GRPN, GNCA and LAB among mid-day movers
Genocea Biosciences to shut down
Genocea Closes Shop, Delists From NASDAQ
See More Headlines

GNCA Stock Analysis - Frequently Asked Questions

Genocea Biosciences, Inc. (NASDAQ:GNCA) announced its earnings results on Wednesday, October, 27th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.15. The biotechnology company earned $1.64 million during the quarter.

Shares of GNCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genocea Biosciences investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), Chipotle Mexican Grill (CMG), BlackRock (BLK), Aegean Marine Petroleum Network (ANW) and Micron Technology (MU).

Company Calendar

Last Earnings
10/27/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GNCA
CIK
1457612
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.61)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$33.20 million
Net Margins
N/A
Pretax Margin
-1,946.15%
Return on Equity
-182.88%
Return on Assets
-62.76%

Debt

Debt-to-Equity Ratio
0.24
Current Ratio
1.35
Quick Ratio
1.35

Sales & Book Value

Annual Sales
$1.91 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.47 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
58,730,000
Free Float
57,788,000
Market Cap
$6 thousand
Optionable
Not Optionable
Beta
1.61

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:GNCA) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners